User login
Article Type
Changed
Wed, 07/25/2018 - 10:13
Table of Contents
- The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA
- Systems Automation for Cancer Surveillance: A Lean Six Sigma Project for Tracking Care of Patients With Head and Neck Cancer
- Open Clinical Trials for Patients With Renal Cell Carcinoma
- Innovations Lead to More Targeted Prostate Cancer Treatments
- Depression Screening and Treatment: A Missed Opportunity in Lung Cancer Care
- Acute Leukemia of Ambiguous Lineage in Elderly Patients: A SEER Medicare Database Analysis
- Treatment and Management of Patients With Non-Small Cell Lung Cancer
- Do Erythropoiesis-Stimulating Agents Have a Risk Evaluation and Mitigation Strategy?
Publications
Sections
Table of Contents
- The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA
- Systems Automation for Cancer Surveillance: A Lean Six Sigma Project for Tracking Care of Patients With Head and Neck Cancer
- Open Clinical Trials for Patients With Renal Cell Carcinoma
- Innovations Lead to More Targeted Prostate Cancer Treatments
- Depression Screening and Treatment: A Missed Opportunity in Lung Cancer Care
- Acute Leukemia of Ambiguous Lineage in Elderly Patients: A SEER Medicare Database Analysis
- Treatment and Management of Patients With Non-Small Cell Lung Cancer
- Do Erythropoiesis-Stimulating Agents Have a Risk Evaluation and Mitigation Strategy?
Table of Contents
- The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA
- Systems Automation for Cancer Surveillance: A Lean Six Sigma Project for Tracking Care of Patients With Head and Neck Cancer
- Open Clinical Trials for Patients With Renal Cell Carcinoma
- Innovations Lead to More Targeted Prostate Cancer Treatments
- Depression Screening and Treatment: A Missed Opportunity in Lung Cancer Care
- Acute Leukemia of Ambiguous Lineage in Elderly Patients: A SEER Medicare Database Analysis
- Treatment and Management of Patients With Non-Small Cell Lung Cancer
- Do Erythropoiesis-Stimulating Agents Have a Risk Evaluation and Mitigation Strategy?
Publications
Publications
Article Type
Sections
Citation Override
Fed Pract. 2017 August;34(suppl 5)
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Consolidated Pubs: Do Not Show Source Publication Logo
Use ProPublica
